Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Etobicoke,, Canada Clinical Trials

A listing of Etobicoke,, Canada clinical trials actively recruiting patients volunteers.

RESULTS

Found (28) clinical trials

Study Evaluating "Real World" Treatment Pattern in Previously Treated Hemophilia A Patients Receiving KOVALTRY (Octocog Alfa) for Routine Prophylaxis

Open label, prospective, non-interventional, single arm study in patients receiving KOVALTRY as prophylaxis therapy.

Phase N/A

7.4 miles

Learn More »

Feasibility Trial in Men With Hormone Sensitive Oligometastatic Prostate Cancer

Investigators propose to do a randomized feasibility trial comparing RP vs RT to the prostate in the setting of hormone sensitive oligometastatic prostate cancer. SBRT will be used to treat all of the metastases, and this will be combined with an intermittent ADT approach. Adding systemic chemotherapy will be allowed. ...

Phase N/A

9.76 miles

Learn More »

Local Ablative Therapy For Hormone Sensitive Oligometastatic Prostate Cancer

The standard or usual treatment for this disease is systemic therapy, which includes androgen deprivation therapy (ADT) with or without chemotherapy or hormone therapy. Additionally, for some patients with specific disease features, standard treatment may also include ablative treatment (radiation or surgery) of the prostate gland if this was not ...

Phase N/A

9.76 miles

Learn More »

Toward a Comprehensive Supportive Care Intervention for Older or Frail Men With mCRPC

Study Aim: The previous multi-centre observational study (TOPCOP), funded by Prostate Cancer Canada, demonstrated important declines in multiple areas of quality of life, and fatigue and functional decline which were common issues that often limited further treatment. Emerging data from other settings demonstrate that (a) close monitoring of symptoms may ...

Phase N/A

9.76 miles

Learn More »

Conventional Ultrasound for Imaging of Prostate Cancer Extent and Response in Human Cancer Patients

This project is an early validation study in human subjects that will use ultrasound imaging and spectroscopy to predict the tumour extent before treatment so that this may allow the most appropriate treatment intervention to be individualised to patients. For examples, patients with evidence of extra-prostatic tissue involvement may be ...

Phase N/A

9.76 miles

Learn More »

Stereotactic Radiotherapy for Oligometastatic Prostate Cancer

Patients will receive androgen deprivation therapy (ADT) for a minimum of 1 year. After this, an intermittent hormone therapy approach will be taken, where ADT will not be restarted until the prostate specific antigen (PSA) reaches a minimum of 10-15 ng/mL. Lupron 30 mg IM will be delivered every 4 ...

Phase N/A

9.76 miles

Learn More »

Prostate Screening Study Using MRI in BRCA Carriers

To determine the value of using Multispectral 3T MRI (MS3TMRI) for prostate cancer screening in men with a high risk of developing early onset aggressive prostate cancer given known BRCA1 or BRCA2 mutation carrier status, with no prior prostate cancer diagnosis, independent of baseline PSA levels. Determine the prevalence of ...

Phase N/A

9.76 miles

Learn More »

5 Fractions of Pelvic SABR With Intra Prostatic SABR Boost:

Stereotactic Ablative Body Radiotherapy (SABR) given in 5 weekly fractions. Simultaneously treating the pelvic lymph nodes, prostate and MRI-nodule to a total dose of 25 Gy, 35 Gy and up to 50 Gy, respectively. The radiation will be given with 6-18 months of ADT. 5-fraction SABR is a feasible, well-tolerated, ...

Phase N/A

9.76 miles

Learn More »